CliffBio
small molecule

MICROZIDE

HYDROCHLOROTHIAZIDE

Loss of exclusivity—loss of exclusivity
CompanyTEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLC

Drug detail

Brand nameMICROZIDE
Active ingredientHYDROCHLOROTHIAZIDE
Strength12.5MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalDecember 1996
Marketing statusRX

More from TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

MICROZIDE patent cliff — loss of exclusivity — | CliffBio